

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 4.87881619 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 4.87881619 |
| 3 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.54126115 |
| 4 | purine nucleobase biosynthetic process (GO:0009113) | 4.36139440 |
| 5 | nucleobase biosynthetic process (GO:0046112) | 4.24977995 |
| 6 | positive regulation of hormone biosynthetic process (GO:0046886) | 4.24538146 |
| 7 | establishment of integrated proviral latency (GO:0075713) | 4.23160479 |
| 8 | positive regulation of megakaryocyte differentiation (GO:0045654) | 4.20075265 |
| 9 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.97614180 |
| 10 | formation of translation preinitiation complex (GO:0001731) | 3.95607461 |
| 11 | chromatin remodeling at centromere (GO:0031055) | 3.93820518 |
| 12 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 3.92006723 |
| 13 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.74671964 |
| 14 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.74393346 |
| 15 | establishment of viral latency (GO:0019043) | 3.69344117 |
| 16 | cullin deneddylation (GO:0010388) | 3.63592862 |
| 17 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.57293653 |
| 18 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.53738088 |
| 19 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.52996927 |
| 20 | protein deneddylation (GO:0000338) | 3.52160868 |
| 21 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.50297838 |
| 22 | chaperone-mediated protein transport (GO:0072321) | 3.48995848 |
| 23 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.47096923 |
| 24 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.46067584 |
| 25 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.41360004 |
| 26 | negative regulation of ligase activity (GO:0051352) | 3.41360004 |
| 27 | regulation of mitochondrial translation (GO:0070129) | 3.36473494 |
| 28 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 3.32042630 |
| 29 | protein retention in ER lumen (GO:0006621) | 3.31881871 |
| 30 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 3.24089016 |
| 31 | protein localization to chromosome, centromeric region (GO:0071459) | 3.23750587 |
| 32 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.21820195 |
| 33 | tRNA aminoacylation for protein translation (GO:0006418) | 3.20842655 |
| 34 | signal peptide processing (GO:0006465) | 3.18990895 |
| 35 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.17688648 |
| 36 | L-serine metabolic process (GO:0006563) | 3.17452119 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.12917260 |
| 38 | regulation of histone H3-K9 methylation (GO:0051570) | 3.12343146 |
| 39 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.11177450 |
| 40 | tRNA aminoacylation (GO:0043039) | 3.10271080 |
| 41 | amino acid activation (GO:0043038) | 3.10271080 |
| 42 | mitotic metaphase plate congression (GO:0007080) | 3.10172012 |
| 43 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 3.09955488 |
| 44 | protein K6-linked ubiquitination (GO:0085020) | 3.07678182 |
| 45 | histone exchange (GO:0043486) | 3.07625435 |
| 46 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.07112021 |
| 47 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.06789334 |
| 48 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.06789334 |
| 49 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.06789334 |
| 50 | DNA strand elongation (GO:0022616) | 3.06372932 |
| 51 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.05706656 |
| 52 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.05706656 |
| 53 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.05623033 |
| 54 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.05484011 |
| 55 | regulation of translation in response to stress (GO:0043555) | 3.04477011 |
| 56 | serine family amino acid biosynthetic process (GO:0009070) | 3.04245406 |
| 57 | positive regulation of ligase activity (GO:0051351) | 3.02357342 |
| 58 | proteasome assembly (GO:0043248) | 3.01583834 |
| 59 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.01520122 |
| 60 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.01520122 |
| 61 | ribosome assembly (GO:0042255) | 3.01062554 |
| 62 | positive regulation of hormone metabolic process (GO:0032352) | 2.99663449 |
| 63 | tetrahydrofolate metabolic process (GO:0046653) | 2.99089033 |
| 64 | protein maturation by protein folding (GO:0022417) | 2.98528877 |
| 65 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.98486010 |
| 66 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.96437138 |
| 67 | IMP biosynthetic process (GO:0006188) | 2.95299919 |
| 68 | DNA ligation (GO:0006266) | 2.93801571 |
| 69 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.92721587 |
| 70 | cellular copper ion homeostasis (GO:0006878) | 2.91265380 |
| 71 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.89700422 |
| 72 | folic acid metabolic process (GO:0046655) | 2.89367406 |
| 73 | regulation of meiosis I (GO:0060631) | 2.89186225 |
| 74 | nuclear pore organization (GO:0006999) | 2.88911060 |
| 75 | telomere maintenance via recombination (GO:0000722) | 2.87755036 |
| 76 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.87728875 |
| 77 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.87728875 |
| 78 | DNA replication checkpoint (GO:0000076) | 2.86950464 |
| 79 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.86564240 |
| 80 | DNA replication-independent nucleosome organization (GO:0034724) | 2.86564240 |
| 81 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.86225842 |
| 82 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.85829923 |
| 83 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.84371362 |
| 84 | DNA double-strand break processing (GO:0000729) | 2.82249380 |
| 85 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.82179284 |
| 86 | protein-cofactor linkage (GO:0018065) | 2.80703252 |
| 87 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.78364531 |
| 88 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.77405829 |
| 89 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.77059628 |
| 90 | L-methionine salvage (GO:0071267) | 2.75380250 |
| 91 | L-methionine biosynthetic process (GO:0071265) | 2.75380250 |
| 92 | amino acid salvage (GO:0043102) | 2.75380250 |
| 93 | copper ion homeostasis (GO:0055070) | 2.75278031 |
| 94 | non-recombinational repair (GO:0000726) | 2.73949533 |
| 95 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.73949533 |
| 96 | DNA deamination (GO:0045006) | 2.73825191 |
| 97 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.73028885 |
| 98 | termination of RNA polymerase III transcription (GO:0006386) | 2.73028885 |
| 99 | mitotic nuclear envelope disassembly (GO:0007077) | 2.72145950 |
| 100 | glycine metabolic process (GO:0006544) | 2.71453609 |
| 101 | positive regulation of cell cycle arrest (GO:0071158) | 2.71270411 |
| 102 | COPII vesicle coating (GO:0048208) | 2.69917873 |
| 103 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.69646737 |
| 104 | mitotic recombination (GO:0006312) | 2.69083572 |
| 105 | nucleoside salvage (GO:0043174) | 2.68787049 |
| 106 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.68435329 |
| 107 | granulocyte differentiation (GO:0030851) | 2.67646428 |
| 108 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.67504658 |
| 109 | regulation of ligase activity (GO:0051340) | 2.67202295 |
| 110 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.66857548 |
| 111 | cell cycle G1/S phase transition (GO:0044843) | 2.66857548 |
| 112 | protein localization to kinetochore (GO:0034501) | 2.66359730 |
| 113 | pseudouridine synthesis (GO:0001522) | 2.65525450 |
| 114 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.64893117 |
| 115 | ribosomal small subunit assembly (GO:0000028) | 2.64575760 |
| 116 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.64567528 |
| 117 | cysteine metabolic process (GO:0006534) | 2.63893352 |
| 118 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.63560042 |
| 119 | spliceosomal snRNP assembly (GO:0000387) | 2.62945562 |
| 120 | folic acid-containing compound metabolic process (GO:0006760) | 2.62919062 |
| 121 | synapsis (GO:0007129) | 2.62412526 |
| 122 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 2.60420023 |
| 123 | ribosomal large subunit biogenesis (GO:0042273) | 2.60326993 |
| 124 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.60027434 |
| 125 | negative regulation of protein ubiquitination (GO:0031397) | 2.59863674 |
| 126 | rRNA modification (GO:0000154) | 2.56949146 |
| 127 | ribosome biogenesis (GO:0042254) | 2.56477220 |
| 128 | metaphase plate congression (GO:0051310) | 2.54764876 |
| 129 | postreplication repair (GO:0006301) | 2.54661861 |
| 130 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.50207647 |
| 131 | UMP metabolic process (GO:0046049) | 2.50207647 |
| 132 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.50207647 |
| 133 | UMP biosynthetic process (GO:0006222) | 2.50207647 |
| 134 | DNA unwinding involved in DNA replication (GO:0006268) | 2.49407490 |
| 135 | DNA replication initiation (GO:0006270) | 2.48058826 |
| 136 | mitotic spindle assembly checkpoint (GO:0007094) | 2.46977611 |
| 137 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.46460843 |
| 138 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.45892526 |
| 139 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.45892526 |
| 140 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.45892526 |
| 141 | negative regulation of sister chromatid segregation (GO:0033046) | 2.45892526 |
| 142 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.45210329 |
| 143 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.45118294 |
| 144 | CENP-A containing nucleosome assembly (GO:0034080) | 2.44849289 |
| 145 | membrane disassembly (GO:0030397) | 2.44082584 |
| 146 | nuclear envelope disassembly (GO:0051081) | 2.44082584 |
| 147 | IMP metabolic process (GO:0046040) | 2.42671317 |
| 148 | establishment of chromosome localization (GO:0051303) | 2.42466080 |
| 149 | viral mRNA export from host cell nucleus (GO:0046784) | 2.41780854 |
| 150 | negative regulation of chromosome segregation (GO:0051985) | 2.41567199 |
| 151 | regulation of spindle organization (GO:0090224) | 2.41494390 |
| 152 | telomere maintenance via telomere lengthening (GO:0010833) | 2.41063202 |
| 153 | spindle assembly checkpoint (GO:0071173) | 2.40318996 |
| 154 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.38429412 |
| 155 | GDP-mannose metabolic process (GO:0019673) | 2.38127381 |
| 156 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.36714783 |
| 157 | pteridine-containing compound metabolic process (GO:0042558) | 2.36122610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.48938691 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.45993033 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.41043828 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.39764967 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.25937810 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.99472371 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.98571123 |
| 8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.93924801 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.92719124 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.69182805 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.57182424 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.52113898 |
| 13 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.45741143 |
| 14 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.33629408 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.29318126 |
| 16 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.25574656 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.25439637 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.19561361 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.18285214 |
| 20 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.17319457 |
| 21 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.07537598 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.06794628 |
| 23 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.04159399 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.02103646 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.96325700 |
| 26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.94624922 |
| 27 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92435654 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.88920903 |
| 29 | * MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.86560909 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.80880722 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79753205 |
| 32 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.79697481 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.72423676 |
| 34 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.71571056 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.70443404 |
| 36 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.66732182 |
| 37 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.66225939 |
| 38 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.65741389 |
| 39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.65434577 |
| 40 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.64024708 |
| 41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.63240185 |
| 42 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.62504684 |
| 43 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.61696384 |
| 44 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.60503663 |
| 45 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.60422296 |
| 46 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.57509402 |
| 47 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.57472083 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.55883949 |
| 49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.49246865 |
| 50 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.45024001 |
| 51 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.43382425 |
| 52 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.43348577 |
| 53 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.42804974 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41731168 |
| 55 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.38680295 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38150976 |
| 57 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.37784417 |
| 58 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.36571529 |
| 59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.35932958 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34369888 |
| 61 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.33795130 |
| 62 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.31814179 |
| 63 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.31367852 |
| 64 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31213958 |
| 65 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.29993523 |
| 66 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29469811 |
| 67 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.29351195 |
| 68 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.29244275 |
| 69 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.27911697 |
| 70 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.26246791 |
| 71 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20340389 |
| 72 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19601846 |
| 73 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.19594010 |
| 74 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19277713 |
| 75 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19254303 |
| 76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14893404 |
| 77 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14711775 |
| 78 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.14511387 |
| 79 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14339422 |
| 80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14160263 |
| 81 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13885257 |
| 82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12875307 |
| 83 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.11999099 |
| 84 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.10684693 |
| 85 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.10411128 |
| 86 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.08523840 |
| 87 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.08051341 |
| 88 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.08051341 |
| 89 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.08051341 |
| 90 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.07830863 |
| 91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06822570 |
| 92 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.06711123 |
| 93 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06425592 |
| 94 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.06017454 |
| 95 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05227006 |
| 96 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.04680652 |
| 97 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.03496009 |
| 98 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.03491695 |
| 99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01635144 |
| 100 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01621360 |
| 101 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.99279364 |
| 102 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98951568 |
| 103 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98352080 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97645529 |
| 105 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.97361087 |
| 106 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97064133 |
| 107 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95878640 |
| 108 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.95103815 |
| 109 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94598968 |
| 110 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.93751108 |
| 111 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.93234226 |
| 112 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.92800057 |
| 113 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.90690526 |
| 114 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88036703 |
| 115 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87121237 |
| 116 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.86235461 |
| 117 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.84515851 |
| 118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84104163 |
| 119 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.80885370 |
| 120 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.75408645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.40937734 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.26695888 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.25571239 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 2.78045820 |
| 5 | MP0006054_spinal_hemorrhage | 2.44951266 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.41340237 |
| 7 | MP0002254_reproductive_system_inflammat | 2.25792444 |
| 8 | MP0003077_abnormal_cell_cycle | 2.16336852 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.11305690 |
| 10 | MP0003186_abnormal_redox_activity | 2.08784191 |
| 11 | MP0005503_abnormal_tendon_morphology | 2.05548333 |
| 12 | MP0009840_abnormal_foam_cell | 2.02052587 |
| 13 | MP0008007_abnormal_cellular_replicative | 1.96536180 |
| 14 | MP0004272_abnormal_basement_membrane | 1.95112174 |
| 15 | MP0003111_abnormal_nucleus_morphology | 1.91550698 |
| 16 | MP0008932_abnormal_embryonic_tissue | 1.86457739 |
| 17 | MP0010094_abnormal_chromosome_stability | 1.76515523 |
| 18 | MP0005365_abnormal_bile_salt | 1.75114040 |
| 19 | MP0008058_abnormal_DNA_repair | 1.65870043 |
| 20 | MP0005083_abnormal_biliary_tract | 1.65248316 |
| 21 | MP0003195_calcinosis | 1.64742514 |
| 22 | MP0003279_aneurysm | 1.63899302 |
| 23 | MP0010030_abnormal_orbit_morphology | 1.62886091 |
| 24 | MP0001730_embryonic_growth_arrest | 1.60643694 |
| 25 | MP0003123_paternal_imprinting | 1.54730885 |
| 26 | MP0006035_abnormal_mitochondrial_morpho | 1.53818843 |
| 27 | MP0005023_abnormal_wound_healing | 1.52111087 |
| 28 | MP0001853_heart_inflammation | 1.51294428 |
| 29 | MP0009697_abnormal_copulation | 1.49339934 |
| 30 | MP0001346_abnormal_lacrimal_gland | 1.46971159 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.46528163 |
| 32 | MP0005085_abnormal_gallbladder_physiolo | 1.43922797 |
| 33 | MP0003315_abnormal_perineum_morphology | 1.42738402 |
| 34 | MP0005360_urolithiasis | 1.42113614 |
| 35 | MP0006082_CNS_inflammation | 1.41442063 |
| 36 | MP0005275_abnormal_skin_tensile | 1.37194779 |
| 37 | MP0010352_gastrointestinal_tract_polyps | 1.35704375 |
| 38 | MP0004264_abnormal_extraembryonic_tissu | 1.29112217 |
| 39 | MP0003567_abnormal_fetal_cardiomyocyte | 1.28992449 |
| 40 | MP0009672_abnormal_birth_weight | 1.28568698 |
| 41 | MP0009053_abnormal_anal_canal | 1.28163671 |
| 42 | MP0003786_premature_aging | 1.26676692 |
| 43 | MP0003984_embryonic_growth_retardation | 1.25705686 |
| 44 | MP0001542_abnormal_bone_strength | 1.25702997 |
| 45 | MP0001672_abnormal_embryogenesis/_devel | 1.25168055 |
| 46 | MP0005380_embryogenesis_phenotype | 1.25168055 |
| 47 | MP0002088_abnormal_embryonic_growth/wei | 1.23106037 |
| 48 | MP0010368_abnormal_lymphatic_system | 1.22014896 |
| 49 | MP0001697_abnormal_embryo_size | 1.21092112 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.20738976 |
| 51 | MP0000490_abnormal_crypts_of | 1.19559491 |
| 52 | MP0000372_irregular_coat_pigmentation | 1.15419949 |
| 53 | MP0002938_white_spotting | 1.15371361 |
| 54 | MP0001915_intracranial_hemorrhage | 1.14350343 |
| 55 | MP0005408_hypopigmentation | 1.13975042 |
| 56 | MP0000350_abnormal_cell_proliferation | 1.13021773 |
| 57 | MP0005332_abnormal_amino_acid | 1.12872310 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.11761206 |
| 59 | MP0004197_abnormal_fetal_growth/weight/ | 1.09095088 |
| 60 | MP0005508_abnormal_skeleton_morphology | 1.08730475 |
| 61 | MP0002080_prenatal_lethality | 1.07882708 |
| 62 | MP0005084_abnormal_gallbladder_morpholo | 1.06615030 |
| 63 | MP0001764_abnormal_homeostasis | 1.06045252 |
| 64 | MP0009384_cardiac_valve_regurgitation | 1.05224977 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.00885020 |
| 66 | MP0003718_maternal_effect | 0.98694973 |
| 67 | MP0003252_abnormal_bile_duct | 0.98163182 |
| 68 | MP0003942_abnormal_urinary_system | 0.97630549 |
| 69 | MP0002653_abnormal_ependyma_morphology | 0.96325001 |
| 70 | MP0001919_abnormal_reproductive_system | 0.96135071 |
| 71 | MP0000598_abnormal_liver_morphology | 0.95685959 |
| 72 | MP0005319_abnormal_enzyme/_coenzyme | 0.95226329 |
| 73 | MP0006292_abnormal_olfactory_placode | 0.95073120 |
| 74 | MP0002086_abnormal_extraembryonic_tissu | 0.94973169 |
| 75 | MP0000358_abnormal_cell_content/ | 0.94796681 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 0.93633641 |
| 77 | MP0004084_abnormal_cardiac_muscle | 0.93530511 |
| 78 | MP0009278_abnormal_bone_marrow | 0.92468796 |
| 79 | MP0005670_abnormal_white_adipose | 0.90161008 |
| 80 | MP0010329_abnormal_lipoprotein_level | 0.89965431 |
| 81 | MP0010307_abnormal_tumor_latency | 0.88911333 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 0.87966706 |
| 83 | MP0003941_abnormal_skin_development | 0.87951967 |
| 84 | MP0005076_abnormal_cell_differentiation | 0.86816228 |
| 85 | MP0000534_abnormal_ureter_morphology | 0.86793741 |
| 86 | MP0001756_abnormal_urination | 0.86559962 |
| 87 | MP0001958_emphysema | 0.86309012 |
| 88 | MP0005165_increased_susceptibility_to | 0.85188971 |
| 89 | MP0001881_abnormal_mammary_gland | 0.85105243 |
| 90 | MP0002085_abnormal_embryonic_tissue | 0.84951894 |
| 91 | MP0003943_abnormal_hepatobiliary_system | 0.84864008 |
| 92 | MP0008057_abnormal_DNA_replication | 0.83878979 |
| 93 | MP0005623_abnormal_meninges_morphology | 0.83657834 |
| 94 | MP0001929_abnormal_gametogenesis | 0.83475303 |
| 95 | MP0000613_abnormal_salivary_gland | 0.83262788 |
| 96 | MP0002210_abnormal_sex_determination | 0.83211093 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.82905206 |
| 98 | MP0003119_abnormal_digestive_system | 0.82586686 |
| 99 | MP0002160_abnormal_reproductive_system | 0.82320979 |
| 100 | MP0002090_abnormal_vision | 0.81997113 |
| 101 | MP0001293_anophthalmia | 0.81621879 |
| 102 | MP0002277_abnormal_respiratory_mucosa | 0.81399989 |
| 103 | MP0005075_abnormal_melanosome_morpholog | 0.81123685 |
| 104 | MP0005220_abnormal_exocrine_pancreas | 0.80970127 |
| 105 | MP0003191_abnormal_cellular_cholesterol | 0.80152225 |
| 106 | MP0001145_abnormal_male_reproductive | 0.79275327 |
| 107 | MP0003936_abnormal_reproductive_system | 0.79210205 |
| 108 | MP0002084_abnormal_developmental_patter | 0.79190982 |
| 109 | MP0001666_abnormal_nutrient_absorption | 0.79082012 |
| 110 | MP0008260_abnormal_autophagy | 0.78779188 |
| 111 | MP0005389_reproductive_system_phenotype | 0.77943477 |
| 112 | MP0009643_abnormal_urine_homeostasis | 0.77093925 |
| 113 | MP0009785_altered_susceptibility_to | 0.76426866 |
| 114 | MP0002877_abnormal_melanocyte_morpholog | 0.76280442 |
| 115 | MP0005367_renal/urinary_system_phenotyp | 0.76248496 |
| 116 | MP0000516_abnormal_urinary_system | 0.76248496 |
| 117 | MP0000609_abnormal_liver_physiology | 0.76165021 |
| 118 | MP0005410_abnormal_fertilization | 0.76065668 |
| 119 | MP0004147_increased_porphyrin_level | 0.76027340 |
| 120 | MP0002138_abnormal_hepatobiliary_system | 0.73838416 |
| 121 | MP0000313_abnormal_cell_death | 0.73771080 |
| 122 | MP0000653_abnormal_sex_gland | 0.73162341 |
| 123 | MP0000858_altered_metastatic_potential | 0.73022331 |
| 124 | MP0002282_abnormal_trachea_morphology | 0.71007209 |
| 125 | MP0002111_abnormal_tail_morphology | 0.70918572 |
| 126 | MP0009703_decreased_birth_body | 0.70736238 |
| 127 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70672741 |
| 128 | MP0005390_skeleton_phenotype | 0.70550018 |
| 129 | MP0002132_abnormal_respiratory_system | 0.70056792 |
| 130 | MP0004019_abnormal_vitamin_homeostasis | 0.69973263 |
| 131 | MP0002019_abnormal_tumor_incidence | 0.69269413 |
| 132 | MP0001984_abnormal_olfaction | 0.69196644 |
| 133 | MP0005310_abnormal_salivary_gland | 0.69022942 |
| 134 | MP0003937_abnormal_limbs/digits/tail_de | 0.68761262 |
| 135 | MP0006036_abnormal_mitochondrial_physio | 0.67924731 |
| 136 | MP0003890_abnormal_embryonic-extraembry | 0.67808437 |
| 137 | MP0001119_abnormal_female_reproductive | 0.66653372 |
| 138 | MP0008873_increased_physiological_sensi | 0.66008356 |
| 139 | MP0009763_increased_sensitivity_to | 0.65746809 |
| 140 | MP0005174_abnormal_tail_pigmentation | 0.64836388 |
| 141 | MP0000627_abnormal_mammary_gland | 0.63390446 |
| 142 | MP0001324_abnormal_eye_pigmentation | 0.63387794 |
| 143 | MP0002006_tumorigenesis | 0.62744544 |
| 144 | MP0009764_decreased_sensitivity_to | 0.61746678 |
| 145 | MP0005671_abnormal_response_to | 0.61391871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 3.68711029 |
| 2 | Protrusio acetabuli (HP:0003179) | 3.50269133 |
| 3 | Abnormality of the anterior horn cell (HP:0006802) | 3.47163153 |
| 4 | Degeneration of anterior horn cells (HP:0002398) | 3.47163153 |
| 5 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.40999002 |
| 6 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.40999002 |
| 7 | Premature rupture of membranes (HP:0001788) | 3.38287371 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.18832027 |
| 9 | Acute encephalopathy (HP:0006846) | 3.18016523 |
| 10 | Hepatocellular necrosis (HP:0001404) | 3.08742006 |
| 11 | Vertebral compression fractures (HP:0002953) | 3.07366537 |
| 12 | Abnormal protein glycosylation (HP:0012346) | 3.04827163 |
| 13 | Abnormal glycosylation (HP:0012345) | 3.04827163 |
| 14 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.04827163 |
| 15 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.04827163 |
| 16 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.03529735 |
| 17 | Increased serum pyruvate (HP:0003542) | 3.00523921 |
| 18 | Abnormality of glycolysis (HP:0004366) | 3.00523921 |
| 19 | Carpal bone hypoplasia (HP:0001498) | 2.96843291 |
| 20 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.96013678 |
| 21 | Stenosis of the external auditory canal (HP:0000402) | 2.95906932 |
| 22 | Increased CSF lactate (HP:0002490) | 2.91516655 |
| 23 | Biconcave vertebral bodies (HP:0004586) | 2.90590593 |
| 24 | Rough bone trabeculation (HP:0100670) | 2.88752008 |
| 25 | Reduced antithrombin III activity (HP:0001976) | 2.82073751 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 2.81706656 |
| 27 | Mitochondrial inheritance (HP:0001427) | 2.78226071 |
| 28 | Cervical subluxation (HP:0003308) | 2.78196394 |
| 29 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.72102109 |
| 30 | Reticulocytopenia (HP:0001896) | 2.70780483 |
| 31 | Poor head control (HP:0002421) | 2.69028151 |
| 32 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.68224084 |
| 33 | Cerebral edema (HP:0002181) | 2.67558809 |
| 34 | Meckel diverticulum (HP:0002245) | 2.66893007 |
| 35 | Lactic acidosis (HP:0003128) | 2.62641593 |
| 36 | Increased hepatocellular lipid droplets (HP:0006565) | 2.62026186 |
| 37 | Metaphyseal cupping (HP:0003021) | 2.60989513 |
| 38 | Increased serum lactate (HP:0002151) | 2.59936786 |
| 39 | Gonadotropin excess (HP:0000837) | 2.59805516 |
| 40 | Cerebral hypomyelination (HP:0006808) | 2.59715062 |
| 41 | Aplastic anemia (HP:0001915) | 2.59582552 |
| 42 | Chromsome breakage (HP:0040012) | 2.56813087 |
| 43 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.55480788 |
| 44 | Abnormality of the ileum (HP:0001549) | 2.55305513 |
| 45 | Abnormality of the intrinsic pathway (HP:0010989) | 2.51654884 |
| 46 | Pancytopenia (HP:0001876) | 2.51570002 |
| 47 | Multiple enchondromatosis (HP:0005701) | 2.50128563 |
| 48 | Hyperglycinuria (HP:0003108) | 2.49998587 |
| 49 | Abnormality of the umbilical cord (HP:0010881) | 2.47992680 |
| 50 | Intrahepatic cholestasis (HP:0001406) | 2.46541435 |
| 51 | Lipid accumulation in hepatocytes (HP:0006561) | 2.46078162 |
| 52 | Hypoglycemic seizures (HP:0002173) | 2.44287060 |
| 53 | Breast hypoplasia (HP:0003187) | 2.44170288 |
| 54 | Beaking of vertebral bodies (HP:0004568) | 2.43456285 |
| 55 | Birth length less than 3rd percentile (HP:0003561) | 2.34697583 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.33919471 |
| 57 | CNS demyelination (HP:0007305) | 2.32925347 |
| 58 | Loss of speech (HP:0002371) | 2.31918513 |
| 59 | Colon cancer (HP:0003003) | 2.31752490 |
| 60 | Abnormal lung lobation (HP:0002101) | 2.28978688 |
| 61 | Premature ovarian failure (HP:0008209) | 2.28840785 |
| 62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.26634585 |
| 63 | Poikiloderma (HP:0001029) | 2.26288617 |
| 64 | Progressive macrocephaly (HP:0004481) | 2.26272127 |
| 65 | Hyperglycemia (HP:0003074) | 2.23882648 |
| 66 | Nonimmune hydrops fetalis (HP:0001790) | 2.21912622 |
| 67 | Abnormal number of erythroid precursors (HP:0012131) | 2.21339346 |
| 68 | Neoplasm of the adrenal gland (HP:0100631) | 2.18319433 |
| 69 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.17111155 |
| 70 | Abnormality of the preputium (HP:0100587) | 2.14910424 |
| 71 | Horseshoe kidney (HP:0000085) | 2.14027384 |
| 72 | Abnormal trabecular bone morphology (HP:0100671) | 2.13139155 |
| 73 | Abnormal cartilage morphology (HP:0002763) | 2.12714541 |
| 74 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.10321323 |
| 75 | Nausea (HP:0002018) | 2.09201446 |
| 76 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.07869522 |
| 77 | Abnormality of alanine metabolism (HP:0010916) | 2.07869522 |
| 78 | Hyperalaninemia (HP:0003348) | 2.07869522 |
| 79 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.07463502 |
| 80 | Single umbilical artery (HP:0001195) | 2.07463502 |
| 81 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.07463502 |
| 82 | Oral leukoplakia (HP:0002745) | 2.06611022 |
| 83 | Macrocytic anemia (HP:0001972) | 2.06211994 |
| 84 | Soft skin (HP:0000977) | 2.06184742 |
| 85 | Hepatosplenomegaly (HP:0001433) | 2.05489597 |
| 86 | Gout (HP:0001997) | 2.05283604 |
| 87 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.04951756 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 2.04951756 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 2.03559312 |
| 90 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.03559312 |
| 91 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.03559312 |
| 92 | Duodenal stenosis (HP:0100867) | 2.03479595 |
| 93 | Small intestinal stenosis (HP:0012848) | 2.03479595 |
| 94 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.02571030 |
| 95 | Death in infancy (HP:0001522) | 2.01849485 |
| 96 | Hypolipoproteinemia (HP:0010981) | 2.01684308 |
| 97 | Cleft eyelid (HP:0000625) | 2.01643826 |
| 98 | Cortical dysplasia (HP:0002539) | 2.01154811 |
| 99 | Microvesicular hepatic steatosis (HP:0001414) | 2.01137576 |
| 100 | Selective tooth agenesis (HP:0001592) | 2.00645725 |
| 101 | Deep venous thrombosis (HP:0002625) | 2.00102901 |
| 102 | Abnormality of chromosome stability (HP:0003220) | 1.99465770 |
| 103 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99464203 |
| 104 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.98802544 |
| 105 | 3-Methylglutaconic aciduria (HP:0003535) | 1.98481474 |
| 106 | Hyperammonemia (HP:0001987) | 1.98480149 |
| 107 | Bilateral microphthalmos (HP:0007633) | 1.97820727 |
| 108 | Proximal tubulopathy (HP:0000114) | 1.97149438 |
| 109 | Absent thumb (HP:0009777) | 1.97042082 |
| 110 | Abolished electroretinogram (ERG) (HP:0000550) | 1.96064450 |
| 111 | Abnormality of dentin (HP:0010299) | 1.94923365 |
| 112 | Type I transferrin isoform profile (HP:0003642) | 1.93707485 |
| 113 | Patent foramen ovale (HP:0001655) | 1.92808420 |
| 114 | Agnosia (HP:0010524) | 1.91156969 |
| 115 | Megaloblastic anemia (HP:0001889) | 1.91098170 |
| 116 | Abnormality of the common coagulation pathway (HP:0010990) | 1.89366254 |
| 117 | Sparse eyelashes (HP:0000653) | 1.89100797 |
| 118 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.88251662 |
| 119 | Hyperglycinemia (HP:0002154) | 1.86867300 |
| 120 | Lethargy (HP:0001254) | 1.86657226 |
| 121 | Abnormality of methionine metabolism (HP:0010901) | 1.85336156 |
| 122 | Abnormality of serum amino acid levels (HP:0003112) | 1.85168909 |
| 123 | Irregular epiphyses (HP:0010582) | 1.84663854 |
| 124 | Postnatal microcephaly (HP:0005484) | 1.83668649 |
| 125 | Abnormal spermatogenesis (HP:0008669) | 1.83408755 |
| 126 | Blue sclerae (HP:0000592) | 1.83289758 |
| 127 | Respiratory failure (HP:0002878) | 1.83054315 |
| 128 | Ragged-red muscle fibers (HP:0003200) | 1.83035622 |
| 129 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.81136897 |
| 130 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.81136897 |
| 131 | Hypoplasia of the uterus (HP:0000013) | 1.80676545 |
| 132 | Spastic paraparesis (HP:0002313) | 1.80165647 |
| 133 | Platyspondyly (HP:0000926) | 1.79205555 |
| 134 | Abnormality of the duodenum (HP:0002246) | 1.79078599 |
| 135 | Increased intramyocellular lipid droplets (HP:0012240) | 1.78564075 |
| 136 | Facial diplegia (HP:0001349) | 1.78480006 |
| 137 | Epiphyseal stippling (HP:0010655) | 1.76720569 |
| 138 | Rectovaginal fistula (HP:0000143) | 1.76261167 |
| 139 | Rectal fistula (HP:0100590) | 1.76261167 |
| 140 | Missing ribs (HP:0000921) | 1.75620382 |
| 141 | Palpitations (HP:0001962) | 1.74968567 |
| 142 | Opisthotonus (HP:0002179) | 1.74247257 |
| 143 | Fat malabsorption (HP:0002630) | 1.73871576 |
| 144 | Hepatic necrosis (HP:0002605) | 1.73368834 |
| 145 | Vaginal fistula (HP:0004320) | 1.73034180 |
| 146 | Xanthomatosis (HP:0000991) | 1.72544823 |
| 147 | Trismus (HP:0000211) | 1.72202906 |
| 148 | Secondary amenorrhea (HP:0000869) | 1.71560192 |
| 149 | Ovarian neoplasm (HP:0100615) | 1.70479508 |
| 150 | Slender long bone (HP:0003100) | 1.69913201 |
| 151 | Patellar aplasia (HP:0006443) | 1.69810007 |
| 152 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.68470783 |
| 153 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.68313565 |
| 154 | Abnormality of glycine metabolism (HP:0010895) | 1.67308741 |
| 155 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.67308741 |
| 156 | Delayed CNS myelination (HP:0002188) | 1.67201824 |
| 157 | Abnormality of the acetabulum (HP:0003170) | 1.66944449 |
| 158 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.66658086 |
| 159 | Abnormal epiphyseal ossification (HP:0010656) | 1.65155701 |
| 160 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.64966208 |
| 161 | Ankle contracture (HP:0006466) | 1.63261678 |
| 162 | Premature graying of hair (HP:0002216) | 1.63184046 |
| 163 | Prominent metopic ridge (HP:0005487) | 1.62578549 |
| 164 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.62374195 |
| 165 | Hepatocellular carcinoma (HP:0001402) | 1.62280786 |
| 166 | Prolonged neonatal jaundice (HP:0006579) | 1.62059501 |
| 167 | Cardiovascular calcification (HP:0011915) | 1.61800685 |
| 168 | 11 pairs of ribs (HP:0000878) | 1.60653730 |
| 169 | Ureteral duplication (HP:0000073) | 1.60643469 |
| 170 | Tongue fasciculations (HP:0001308) | 1.59701940 |
| 171 | Abnormal pancreas size (HP:0012094) | 1.59308235 |
| 172 | Microretrognathia (HP:0000308) | 1.59130478 |
| 173 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.58496588 |
| 174 | Vacuolated lymphocytes (HP:0001922) | 1.58162121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.82391149 |
| 2 | BUB1 | 3.95637377 |
| 3 | WEE1 | 2.89062551 |
| 4 | MST4 | 2.87451022 |
| 5 | TESK2 | 2.73506856 |
| 6 | TESK1 | 2.67100688 |
| 7 | NEK1 | 2.59412858 |
| 8 | EIF2AK1 | 2.59394927 |
| 9 | BCKDK | 2.49592802 |
| 10 | TSSK6 | 2.23813973 |
| 11 | PLK4 | 2.11221975 |
| 12 | PDK2 | 2.07465151 |
| 13 | PNCK | 2.06208389 |
| 14 | ERN1 | 1.98979356 |
| 15 | TRIB3 | 1.98633214 |
| 16 | CDK19 | 1.93344353 |
| 17 | BRSK2 | 1.90509156 |
| 18 | PASK | 1.87301311 |
| 19 | ACVR1B | 1.86741669 |
| 20 | NME2 | 1.84959806 |
| 21 | EPHA2 | 1.80862312 |
| 22 | SRPK1 | 1.78603393 |
| 23 | TRIM28 | 1.78263659 |
| 24 | PIM2 | 1.76616502 |
| 25 | CCNB1 | 1.73845730 |
| 26 | EIF2AK3 | 1.70250205 |
| 27 | NEK2 | 1.69369956 |
| 28 | PKN2 | 1.69063409 |
| 29 | PAK4 | 1.67384090 |
| 30 | LIMK1 | 1.63429228 |
| 31 | MAP3K12 | 1.53238313 |
| 32 | NEK9 | 1.49681453 |
| 33 | PBK | 1.46945725 |
| 34 | PDK4 | 1.46233926 |
| 35 | PDK3 | 1.46233926 |
| 36 | STK38L | 1.45668063 |
| 37 | CDC7 | 1.44494255 |
| 38 | TTK | 1.42423456 |
| 39 | STK16 | 1.40242022 |
| 40 | TXK | 1.39619926 |
| 41 | PLK3 | 1.37241462 |
| 42 | RPS6KA4 | 1.37182569 |
| 43 | AKT3 | 1.33628064 |
| 44 | PLK1 | 1.30719986 |
| 45 | MAP4K2 | 1.24020378 |
| 46 | KDR | 1.21527415 |
| 47 | TGFBR1 | 1.19429719 |
| 48 | CDK8 | 1.15102080 |
| 49 | BRSK1 | 1.13636343 |
| 50 | ZAK | 1.12581670 |
| 51 | ILK | 1.09809774 |
| 52 | NUAK1 | 1.05703875 |
| 53 | BRAF | 1.03920227 |
| 54 | FLT3 | 1.03280980 |
| 55 | AURKB | 0.97459724 |
| 56 | STK24 | 0.96249174 |
| 57 | MKNK1 | 0.89711491 |
| 58 | ATR | 0.84291380 |
| 59 | ERBB3 | 0.83468643 |
| 60 | LRRK2 | 0.82662745 |
| 61 | MAP3K8 | 0.81927875 |
| 62 | TAF1 | 0.81234872 |
| 63 | NME1 | 0.80294777 |
| 64 | VRK1 | 0.78539542 |
| 65 | TIE1 | 0.78516871 |
| 66 | STK3 | 0.77363803 |
| 67 | ARAF | 0.76882830 |
| 68 | CDK4 | 0.76149135 |
| 69 | CDK7 | 0.75696825 |
| 70 | PAK1 | 0.75284466 |
| 71 | TLK1 | 0.74767909 |
| 72 | BCR | 0.74261566 |
| 73 | CAMK1G | 0.72645876 |
| 74 | AURKA | 0.71884921 |
| 75 | DYRK3 | 0.71048874 |
| 76 | PIM1 | 0.69712076 |
| 77 | WNK4 | 0.67876951 |
| 78 | BMPR1B | 0.67109354 |
| 79 | ZAP70 | 0.65913095 |
| 80 | FGFR4 | 0.64492047 |
| 81 | CLK1 | 0.63971824 |
| 82 | SIK1 | 0.63640875 |
| 83 | PTK6 | 0.59735738 |
| 84 | MET | 0.59583716 |
| 85 | RPS6KB2 | 0.59571349 |
| 86 | CSNK1G3 | 0.58894935 |
| 87 | CSNK2A1 | 0.58858752 |
| 88 | ATM | 0.57250290 |
| 89 | PDGFRA | 0.54607907 |
| 90 | STK4 | 0.53758560 |
| 91 | PRKCI | 0.53465301 |
| 92 | CSNK1G1 | 0.52720142 |
| 93 | IRAK4 | 0.52538339 |
| 94 | TBK1 | 0.51880186 |
| 95 | WNK3 | 0.51093227 |
| 96 | MYLK | 0.48685247 |
| 97 | GRK1 | 0.47514264 |
| 98 | MAP3K11 | 0.45787144 |
| 99 | CSNK1A1L | 0.45435463 |
| 100 | ABL2 | 0.45261731 |
| 101 | DYRK2 | 0.44941844 |
| 102 | FGFR1 | 0.44558301 |
| 103 | CHEK2 | 0.43864651 |
| 104 | CHEK1 | 0.43633041 |
| 105 | CHUK | 0.43158273 |
| 106 | MATK | 0.42293341 |
| 107 | ALK | 0.42243939 |
| 108 | DAPK1 | 0.42241838 |
| 109 | MELK | 0.41548621 |
| 110 | PLK2 | 0.41217639 |
| 111 | YES1 | 0.40885851 |
| 112 | MAP3K5 | 0.39842439 |
| 113 | IRAK3 | 0.39799118 |
| 114 | CSNK2A2 | 0.39551768 |
| 115 | CDK9 | 0.39383207 |
| 116 | STK10 | 0.38789700 |
| 117 | TEC | 0.38552551 |
| 118 | GRK7 | 0.37966565 |
| 119 | OXSR1 | 0.37220606 |
| 120 | INSRR | 0.36874008 |
| 121 | LATS2 | 0.36072568 |
| 122 | MAP3K3 | 0.35677925 |
| 123 | CSNK1G2 | 0.35556601 |
| 124 | CDK6 | 0.35220845 |
| 125 | ERBB4 | 0.35182027 |
| 126 | IRAK1 | 0.34842180 |
| 127 | MAPKAPK5 | 0.34014455 |
| 128 | DDR2 | 0.33381602 |
| 129 | DAPK3 | 0.32839608 |
| 130 | MTOR | 0.32346969 |
| 131 | IGF1R | 0.31249909 |
| 132 | SCYL2 | 0.30240632 |
| 133 | ADRBK2 | 0.30116050 |
| 134 | CDK2 | 0.29121340 |
| 135 | EIF2AK2 | 0.29107602 |
| 136 | PAK2 | 0.27853079 |
| 137 | CSNK1E | 0.27843989 |
| 138 | PRKG2 | 0.27043528 |
| 139 | RAF1 | 0.26802440 |
| 140 | MOS | 0.25168933 |
| 141 | CDK14 | 0.20068060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.78753818 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.84884251 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.58400114 |
| 4 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.51637962 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.14258873 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.12961255 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.07943425 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 1.99091677 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.95996270 |
| 10 | RNA transport_Homo sapiens_hsa03013 | 1.92836068 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.90085235 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 1.85181207 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.84216799 |
| 14 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.83776943 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.78772606 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.77148301 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76896883 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.76418054 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.75059302 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.70986689 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.68492620 |
| 22 | Cell cycle_Homo sapiens_hsa04110 | 1.58938329 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.57952170 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.56900803 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54799151 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.54727432 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49019337 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.45700286 |
| 29 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.37657565 |
| 30 | Ribosome_Homo sapiens_hsa03010 | 1.36186989 |
| 31 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33945888 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.33318454 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.30626643 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.30108098 |
| 35 | Huntingtons disease_Homo sapiens_hsa05016 | 1.28180565 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19745934 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19730701 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.17941882 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17701883 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.15514151 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.12688553 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10301560 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.04979317 |
| 44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03229311 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.03032829 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02716358 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02228470 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.00866439 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.00324782 |
| 50 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00209258 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99110351 |
| 52 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.97002433 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.92010661 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.91519083 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91476742 |
| 56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.89450198 |
| 57 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89111796 |
| 58 | RNA degradation_Homo sapiens_hsa03018 | 0.87001166 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86402325 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86079126 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82633602 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81941461 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.78641653 |
| 64 | Purine metabolism_Homo sapiens_hsa00230 | 0.77424208 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76823998 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75899824 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75537703 |
| 68 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.75251350 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74300690 |
| 70 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.73561164 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.73521716 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71677551 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69827936 |
| 74 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69176571 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67136792 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66307640 |
| 77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65898094 |
| 78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64319331 |
| 79 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64188931 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62027013 |
| 81 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61528014 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59443641 |
| 83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59404998 |
| 84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58254105 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57422873 |
| 86 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.56494570 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55063208 |
| 88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53829059 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53567050 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52692329 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51876930 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51496147 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51121989 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49092825 |
| 95 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47919045 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47511704 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47303391 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.46612793 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.45624149 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44062637 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43646424 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43342154 |
| 103 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42983194 |
| 104 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42877803 |
| 105 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42068428 |
| 106 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41975226 |
| 107 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40978428 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40819555 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40353078 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38954783 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38942986 |
| 112 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.37829270 |
| 113 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.34708299 |
| 114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33696474 |
| 115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31618746 |
| 116 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.27823734 |
| 117 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26021545 |
| 118 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.25564126 |
| 119 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.24455025 |
| 120 | Asthma_Homo sapiens_hsa05310 | 0.23350867 |

